Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ (2006) Cancer statistics, 2006. CA Cancer J Clin 56(2):106–130. https://doi.org/10.3322/canjclin.56.2.106
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bog-dahn U et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996. https://doi.org/10.1056/NEJMoa043330
Article CAS PubMed Google Scholar
Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5‑year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466. https://doi.org/10.1016/S1470-2045(09)70025-7
Article CAS PubMed Google Scholar
Biswas T, Okunieff P, Schell MC, Smudzin T, Pilcher WH, Bakos RS, Vates GE, Walter KA, Wensel A, Korones DN et al (2009) Stereotactic radiosurgery for glioblastoma: retrospective analysis. Radiat Oncol 4:11. https://doi.org/10.1186/1748-717X-4-11
Article PubMed PubMed Central Google Scholar
Niranjan A, Kano H, Iyer A, Kondziolka D, Flickinger JC, Lunsford LD (2015) Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era. J Neurosurg 122:757–765. https://doi.org/10.3171/2014.11.JNS13295
Park KJ, Kano H, Iyer A, Liu X, Niranjan A, Flickinger JC, Lieberman FS, Lunsford LD, Kondziolka D (2012) Salvage gamma knife stereotactic radiosurgery followed by bevacizumab for recurrent glioblastoma multiforme: a case-control study. J Neurooncol 107:323–333. https://doi.org/10.1007/s11060-011-0744-9
Article CAS PubMed Google Scholar
Patel M, Siddiqui F, Jin JY, Mikkelsen T, Rosenblum M, Movsas B, Ryu S (2009) Salvage reirradiation for recurrent glioblastoma with radiosurgery: Radiographic response and improved survival. J Neurooncol 92:185–191. https://doi.org/10.1007/s11060-008-9752-9
Skeie BS, Enger PØ, Brøgger J, Ganz JC, Thorsen F, Heggdal JI, Pedersen PH (2012) γ knife surgery versus reoperation for recurrent glioblastoma multiforme. World Neurosurg 78:658–669. https://doi.org/10.1016/j.wneu.2012.03.024
Bräutigam E, Lampl C, Track C, Nieder C, Pichler J, Hammer J, Geinitz H (2019) Re-irradiation of recurrent glioblastoma as part of a sequential multimodality treatment concept. Clin Transl Oncol 21:582–587. https://doi.org/10.1007/s12094-018-1957-6
Frischer JM, Marosi C, Woehrer A, Hainfellner JA, Dieckmann KU, Eiter H, Wang WT, Mallouhi A, Ertl A, Knosp E et al (2016) Gamma knife radiosurgery in recurrent glioblastoma. Stereotact Funct Neurosurg 94:265–272. https://doi.org/10.1159/000448924
Yazici G, Cengiz M, Ozyigit G, Eren G, Yildiz F, Akyol F, Gurkaynak M, Zorlu F (2014) Hypofractionated stereotactic reirradiation for recurrent glioblastoma. J Neurooncol 120:117–123. https://doi.org/10.1007/s11060-014-1524-0
Martínez-Carrillo M, Tovar-Martín I, Zurita-Herrera M, Del Moral-Ávila R, Guerrero-Tejada R, Saura-Rojas E, Osorio-Ceballos JL, Arrebola-Moreno JP, Expósito-Hernández J (2014) Salvage radiosurgery for selected patients with recurrent malignant gliomas. Biomed Res Int 2:657953
National Comprehensive Cancer Network (2022) Central Nervous System Cancers. https://www.nccn.org/professionals/physician_gls/pdf/cns_blocks.pdf. Accessed 1 Feb 2023
Bloch O, Han SJ, Cha S, Sun MZ, Aghi MK, McDermott MW, Berger MS, Parsa AT (2012) Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article. J Neurosurg 117:1032–1038. https://doi.org/10.3171/2012.9.JNS12504
Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R et al (2009) Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol 27:4733–4740. https://doi.org/10.1200/JCO.2008.19.8721
Article CAS PubMed Google Scholar
Lombardi G, De Salvo GL, Brandes AA, Eoli M, Rudà R, Faedi M, Lolli I, Pace A, Daniele B, Pasqualetti F et al (2019) Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): A multicentre, open-label, randomised, controlled, phase 2 trial. Lancet Oncol 20:110–119. https://doi.org/10.1016/S1470-2045(18)30675-2
Article CAS PubMed Google Scholar
Navarria P, Minniti G, Clerici E, Tomatis S, Pinzi V, Ciammella P, Galaverni M, Amelio D, Scartoni D, Scoccianti S et al (2019) Re-irradiation for recurrent glioma: Outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO). J Neurooncol 142:59–67. https://doi.org/10.1007/s11060-018-03059-x
Article CAS PubMed Google Scholar
Mazzola R, Corradini S, Gregucci F, Figlia V, Fiorentino A, Alongi F (2019) Role of radiosurgery/stereotactic radiotherapy in oligometastatic disease: brain oligometastases. Front Oncol 9:206. https://doi.org/10.3389/fonc.2019.00206
Article PubMed PubMed Central Google Scholar
Meduri B, Gregucci F, D’Angelo E, Alitto AR, Ciurlia E, Desideri I, Marino L, Borghetti P, Fiore M, Fiorentino A, AIRO Giovani -Italian Association of Radiation Oncology-Young Members (2020) Volume de-escalation in radiation therapy: state of the art and new perspectives. J Cancer Res Clin Oncol 146:909–924. https://doi.org/10.1007/s00432-020-03152-7
Gregucci F, Surgo A, Carbonara R, Laera L, Ciliberti MP, Gentile MA et al (2022) Radiosurgery and stereotactic brain radiotherapy with systemic therapy in recurrent high-grade gliomas: is it feasible? Therapeutic strategies in recurrent high-grade Gliomas. J Pers Med 12(8):1336. https://doi.org/10.3390/jpm12081336
Article PubMed PubMed Central Google Scholar
Fogh SE, Andrews DW, Glass J, Curran W, Glass C, Champ C, Evans JJ, Hyslop T, Pequignot E, Downes B et al (2010) Hypofractionated stereotactic radiation therapy: An effective therapy for recurrent high-grade gliomas. J Clin Oncol 28:3048–3053. https://doi.org/10.1200/JCO.2009.25.6941
Article PubMed PubMed Central Google Scholar
Holt DE, Bernard ME, Quan K, Clump DA, Engh JA, Burton SA, Heron DE (2016) Salvage stereotactic radiosurgery for recurrent glioblastoma multiforme with prior radiation therapy. J Cancer Res Ther 12:1243–1248. https://doi.org/10.4103/0973-1482.199537
Article CAS PubMed Google Scholar
Martínez-Garcia M, Álvarez-Linera J, Carrato C, Ley L, Luque R, Maldonado X, Martínez-Aguillo M, Navarro LM, Vaz-Salgado MA, Gil-Gil M (2018) SEOM clinical guidelines for diagnosis and treatment of glioblastoma. Clin Transl Oncol 20:22–28. https://doi.org/10.1007/s12094-017-1763-6
Torok JA, Wegner RE, Mintz AH, Heron DE, Burton SA (2011) Re-irradiation with radiosurgery for recurrent glioblastoma multiforme. Technol Cancer Res Treat 10:253–258. https://doi.org/10.7785/tcrt.2012.500200
Article CAS PubMed Google Scholar
Gigliotti MJ, Hasan S, Karlovits SM, Ranjan T, Wegner RE Re-irradiation with stereotactic radiosurgery/radiotherapy for recurrent high-grade gliomas: Improved survival in the modern era. Stereotact Funct Neurosurg 96:289–295. https://doi.org/10.1159/000493545
Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205–216. https://doi.org/10.1093/jnci/92.3.205
Article CAS PubMed Google Scholar
Alongi F, Fiorentino A, Gregucci F, Corradini S, Giaj-Levra N, Romano L, Rigo M, Ricchetti F, Beltramello A, Lunardi G et al (2019) First experience and clinical results using a new non-coplanar mono-isocenter technique (HyperArc™) for Linac-based VMAT radiosurgery in brain metastases. J Cancer Res Clin Oncol 145:193–200. https://doi.org/10.1007/s00432-018-2781-7
Article CAS PubMed Google Scholar
Gregucci F, Bonaparte I, Surgo A, Caliandro M, Carbonara R, Ciliberti MP, Aga A, Berloco F, De Masi M, De Pascali C et al (2021) Brain linac-based radiation therapy: “test drive” of new immobilization solution and surface guided radiation therapy. J Pers Med 11:1351. https://doi.org/10.3390/jpm11121351
Article PubMed PubMed Central Google Scholar
Gregucci F, Surgo A, Bonaparte I, Laera L, Ciliberti MP, Carbonara R, Gentile MA, Giraldi D, Calbi R, Caliandro M et al (2021) Poor-prognosis patients affected by glioblastoma: retrospective study of hypofractionated radiotherapy with simultaneous integrated boost and concurrent/Adjuvant Temozolomide. J Pers Med 11:1145. https://doi.org/10.3390/jpm11111145
Article PubMed PubMed Central Google Scholar
Stiefel I, Schröder C, Tanadini-Lang S, Pytko I, Vu E, Klement RJ, Guckenberger M, Andratschke N et al (2021) High-dose re-irradiation of intracranial lesions—Efficacy and safety including dosimetric analysis based on accumulated EQD2Gy dose EQD calculation. Clin Transl Radiat Oncol 27:132–138. https://doi.org/10.1016/j.ctro.2021.01.011
Article CAS PubMed PubMed Central Google Scholar
Weller M, van den Bent M, Preusser M, Le Rhun E, Tonn JC, Minniti G, Bendszus M, Balana C, Chinot O, Dirven L et al (2021) EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol 18(3):170–186. https://doi.org/10.1038/s41571-020-00447-z
Hau P, Baumgart U, Pfeifer K, Bock A, Jauch T, Dietrich J, Fabel K, Grauer O, Wismeth C, Klinkhammer-Schalke M et al (2003) Salvage therapy in patients with glioblastoma: Is there any benefit? Cancer 98:2678–2686. https://doi.org/10.1002/cncr.11845
Kondziolka D, Flickinger JC, Bissonette DJ, Bozik M, Lunsford LD (1997) Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms. Neurosurgery 41:776–783. https://doi.org/10.1097/00006123-199710000-00004 (discussion 783–5)
Comments (0)